Flow Traders U.S.’s VivoSim Labs VIVS Stock Holding History

Flow Traders U.S.’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-42	Closed	-$6K	–	650
2020 Q2	$6K	Buy	+42	New	+$5.12K	﹤0.01%	419

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Flow Traders U.S.'s VIVS Position: Q3 2020 in Review

Flow Traders U.S. sold out of VivoSim Labs (VIVS) in Q3 2020, closing a stake of 42 shares — an estimated $6K sold.

Flow Traders U.S. first reported a position in VIVS in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 46 funds tracked by Wall St. Rank hold VIVS as of Q3 2020.

Flow Traders U.S. reported no remaining VivoSim Labs position as of Q3 2020 after selling out during the quarter.
Flow Traders U.S. sold 42 VivoSim Labs shares in Q3 2020, an estimated $6K.
Flow Traders U.S. first reported a position in VivoSim Labs in Q2 2020 and held it in 1 quarter.
Flow Traders U.S.'s VivoSim Labs position peaked at $6K in Q2 2020.
46 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2020.

Based on Flow Traders U.S.'s 13F filing for Q3 2020, filed 16 Nov 2020.